NCT06654817View on ClinicalTrials.gov

Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions

PemphigusPemphigus Vulgaris (PV)

Interventions

DRUG

Ofatumumab subcutaneous injection

To compare the efficacy and safety of two treatment strategies: ofatumumab combined with corticosteroids versus corticosteroids along with azathioprine, in pemphigus patients.

Trial Locations (1)

350000

First Affiliated Hospital of Fujian Medical University, Fuzhou